ArticleFrontiers in immunology2022

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.

Serena De Matteis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.